Acetylsalicylic Acid
Locally Advanced Pancreatic Cancer
Assistance Publique - Hôpitaux de ParisPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Locally Advanced Pancreatic Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Endotag-1 SynCore Biotechnology Co., Ltd. | Phase 3 | B |
Plavix Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Ceralasertib Rahul Aggarwal | Phase 2 | CCC |
Pegteograstim Yonsei University | Phase 2 | CCC |
Same molecule, other indications
Acetylsalicylic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →